Emphysema: New concepts;Emphyseme pulmonaire: evolution des concepts

Medecine/Sciences

Volumn 15, Issue 6-7, 1999, Pages 833-841

  Mal, Hervé ^a   Crestani, Bruno ^b   Aubier, Michel ^b   Fournier, Michel ^a  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTIN; PROTEINASE; PROTEINASE INHIBITOR; RETINOIC ACID;

AIRWAY OBSTRUCTION; DYSPNEA; ENZYME RELEASE; GAS EXCHANGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; LUNG VOLUME; MAJOR CLINICAL STUDY; NEUTROPHIL; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW;

EID: 0032810913     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1440     Document Type: Review

References (51)

1. Snider G, Kleinerman LJ, Thurlbeck WM, Bengali ZH. The definition of emphysema: report of a National Heart, Lung and Blood Institute, Division of lung diseases workshop. Am Rev Respir Dis 1985; 132: 182-5.
2. Finlay GA, O'Donnell MD, O'Connor CM, Hayes JP, Fitzgerald MX. Elastin and collagen remodeling in emphysema. Am J Pathol 1996; 149: 1405-15.
3. Martorana PA, Brand T, Gardi C, et al. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Lab Invest 1993; 68: 233-41.
4. Goldstein RA, Starcher BC. Urinary excretion of elastin peptides containing desmosine after intra-tracheal injection of elastase in hamsters. J Clin Invest 1978; 61: 1286-90.
5. Cardosa WV, Sekhon HS, Hyde DM, Thurlbeck WM. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis 1993; 147: 975-81.
6. Seman M, Montano M, Ramos C, et al. Tobacco-smoke induced emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol 1996; 271: L734-43.
7. Kuhn C, Starcher BC. The effect of lathyrogens on the evolution of elastase-induced emphysema. Am Rev Respir Dis 1980 ; 122: 453-66.
8. Niewohner DE, Hoidal JR. Lung fibrosis and emphysema: divergent responses to a common injury. Science 1982; 217: 359-60.
9. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71: 955-61.
10. Finlay GA, O'Driscoll LR, Russell KJ, JB, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156: 240-7.
11. Huang SL, Su CH, Chang SC. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-9.
12. Fera T, Abboud RT, Richter A, Johal SS. Acute effect of smoking on elastase-like esterase activity and immunologic neutrophil elastase levels in bronchoalveolar lavage fluid. Am Rev Respir Dis 1986; 133: 568-73.
13. Damiano VV, Tsang A, Kucich U, et al. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986; 78: 402-93.
14. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666-72.
15. Niewohner DE, Kleinerman J, Rice DB. Pathological changes in the peripheral airways of young cigarette smokers. N Engl J Med 1977; 291: 755-8.
16. Senior RM, Connelly NL, Cury JD, Welgus HG, Campbell EJ. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am Rev Respir Dis 1989; 139: 1251-6.
17. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002-4.
18. Whitsett JA, Wert SE, Jones T, Fisher J, Korfhagen TR. Spontaneous emphysema in SP-D gene targeted mice. Am J Respir Crit Care Med 1999; 159: A729.
19. Swee M, Parks WC, Pierce RA. Developmental regulation of elastin production: expression of tropoelastin pre-mRNA persists after down regulation of steady-state mRNA levels. J Biol Chem 1995; 270: 14899-906.
20. Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons related radiocarbon. J Clin Invest 1991; 87: 1828-34.
21. Morris SM, Thomas KM, Rich CB, Stone PJ. Degradation and repair of elastic fibers in rat lung interstitial fibroblast cultures. Anat Rec 1998; 250: 397-407.
22. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med 1998; 158: 555-64.
23. Chambers RC, McAnulty RJ, Shock A, Campa JS, Newman Taylor AJ, Laurent GJ. Cadmium selectively inhibits fibroblast procollagen production and proliferation. Am J Physiol 1994; 267: L300-8.
24. Nakamura Y, Romberger DJ, Tate L, et al. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med 1995; 151: 1497-503.
25. Tomek RJ, Rimar S, Eghbali-Webb M. Nicotine regulates collagen gene expression, collagenase activity, and DNA synthesis in cultured cardiac fibroblasts. Mol Cell Biochem 1994; 136: 97-103.
26. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema. Nat Med 1997; 3: 675-7.
27. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in the rat. Am J Physiol (Lung Cell Mol Physiol 14) 1996; 270: L305-10.
28. Wewers MD, Casolaro A, Sellers SE, et al. Replacement therapy for alphal-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316: 1055-62.
29. Barker AF, Siemsen F, Pasley D, D'Silva R, Buist AS. Replacement therapy for hereditary alphal-antitrypsin deficiency. A program for long-term administration. Chest 1994; 105: 1046-50.
30. Alphal-antitrypsin deficiency Group. A registry of patients with severe deficiency of alpha1-antitrypsin. Chest 1994; 106: 1223-32.
31. Alpha-1-antitrypsin Deficiency Study Group. Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin. Am J Respir Crit Care Med 1998; 158: 49-59.
32. Stone PJ, Morris TA, Franzblau C, Snider GL. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha1-antitrypsin-deficient humans. Respiration 1995; 62: 76-9.
33. Mal H, Andreassian B. Place de la chirurgie dans le traitement des bronchopneumopathies obstructives. Rev Mal Respir 1993; 10: 175-81.
34. Snider GL. Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema. Chest 1996; 109: 540-8.
35. Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis 1959; 80: 194-202.
36. Roué C, Mal H, Sleiman C, et al. Lung volume reduction in patients with severe diffuse emphysema. A retrospective study. Chest 1996; 110: 28-34.
37. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-19.
38. Cooper JD, Patterson GA, Sundaresan S, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-30.
39. Cordova F, O'Brien G, Furukawa S, Kuzma AM, Travaline J, Criner GJ. Stability of improvements in exercise performance and quality of life folowing bilateral lung volume reduction surgery in severe COPD. Chest 1997; 112: 907-15.
40. Gelb AF, Brennert M, Mc Kenna RJ, Zamel N, Fischel R, Epstein JD. Lung function 12 months following emphysema resection. Chest 1996; 110: 1407-15.
41. Brenner M, McKenna RJ, Gelb AF, Fishel RJ, Wilson AF. Rate of FEV1 change following lung volume reduction surgery. Chest 1998; 113: 652-9.
42. Russi EW, Stammberger U, Weder W. Lung volume reduction surgery for emphysema. Eur Respir J 1997; 10: 208-18.
43. Weinmann GG, Hyatt R. Evaluation and research in lung volume reduction surgery. Am J Respir Crit Care Med 1996; 54: 1913-8.
44. Criner RJ, O'Brien G, Furukawa S. Lung volume reduction surgery in ventilator-dependent COPD patients. Chest 1996; 110: 877-84.
45. Mal H, Andreassian B, Pamela F, et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis 1989; 140: 797-802.
46. Mal H, Sleiman C, Roué C, et al. Critères de sélection des candidats à la transplantation pulmonaire. Rev Mal Respir 1997; 14: 423-9.
47. Trulock EP. Lung transplantation for COPD. Chest 1998; 113: 269S-76S.
48. Low DE, Trulock EP, Kaiser LR, et al. Morbidity, mortality and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg 1992; 103: 1119-26.
49. Willams TJ, Patterson GA, Mac Lean PA, Zamel N, Maurer JR. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145: 101-5.
50. Manaker S, Tino G. Natural history and prognosis of advanced lung disease. Clin Chest Med 1997; 18: 435-55.
51. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351: 24-7.